Alamab Therapeutics
Manufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
302 Carnegie Ctr Ste 100, Princeton, New...Phone Number
(609) 356-0210Website
www.alamab.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Alamab Therapeutics
AlaMab Therapeutics is an innovative biopharmaceutical company focused on developing first-in-class antibody drugs. Their key products include ALMB-0166, which aims to reduce inflammation and promote nerve regeneration in acute spinal cord injuries, and ALMB-0168, designed to inhibit the growth and spread of bone-related cancers. The company targets healthcare providers and patients affected by spinal cord injuries and bone cancers. They are actively engaged in clinical trials and have received regulatory approvals for their therapies.Explore more
Popular SearchesAlaMab Therapeutics IncAlaMab TheraputicsAlaMab TherapeuticsSIC Code 28,283NAICS Code 32,325Show more
Alamab Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alamab Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Alamab Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Alamab Therapeutics has new funding data
Check out if Alamab Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Alamab Therapeutics
Alamab Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Alamab Therapeutics launches new products
Earning: See what the market has to say on Alamab Therapeutics recently announced quarterly report
Check if Alamab Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Alamab Therapeutics
Find 2 more new buyers
Compare Similar Companies to Alamab Therapeutics
Compare insights from companies similar to Alamab Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alamab Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alamab Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alamab Therapeutics.
Alamab Therapeutics Tech Stack
A closer look at the technologies used by Alamab Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alamab Therapeutics
Sign Up For FreeTo access detailed company insights
AlaMab Therapeutics is an innovative biopharmaceutical company focused on developing first-in-class antibody drugs. Their key products include ALMB-0166, which aims to reduce inflammation and promote nerve regeneration in acute spinal cord injuries, and ALMB-0168, designed to inhibit the growth and spread of bone-related cancers. The company target... Read More
